This is a paid post contributed by a Patch Community Partner. The views expressed in this post are the author's own, and the information presented has not been verified by Patch.
It can be safe when three things are true: a licensed provider evaluates you first, the medication comes from a state-licensed pharmacy you can name, and someone follows up as your dose changes. The risk is in the shortcuts: no exam, no lab work, products labeled "for research use only" and marketing that blurs the line between compounded and FDA-approved medications.
That question carries more weight in 2026 than ever. A GLP-1 medication is now the most-searched aesthetic and wellness treatment in Florida, at roughly 179,000 Google searches a month and climbing, according to RankMedSpa's analysis of search data from September 2025 through August 2026. Over the same stretch, the FDA has repeatedly warned companies that sell these medications online.
Here is what patients in St. Pete, Gulfport and the Pinellas Beaches should know before starting, or before their next refill.
Explore GLP-1 programs at Refresh in St. Petersburg
Mostly marketing that oversells, and products that should never be sold for human use.
The common thread is not telehealth. It is care that skips the medical part.
FDA-approved medications have been reviewed by the FDA for safety, effectiveness and manufacturing quality. Compounded medications are prepared by pharmacies, are not FDA-approved and are not the same as generic drugs, according to the FDA.
The FDA has also said compounding can play an important role when patients have specific needs. What it objects to is marketing that presents a compounded product as identical to a brand-name medication. Before you start any GLP-1, ask which type you are being prescribed, which state-licensed pharmacy prepares it and why it was chosen for you.
Look for these seven things:
A real evaluation also means some people leave without a prescription. That is the point of having one. If a seller cannot answer these questions, that is your answer.
Yes. Two once-daily GLP-1 pills are now FDA-approved for chronic weight management, the first in December 2025 and the second on April 1, 2026. Pills and weekly injections differ in how they are taken, how doses increase and what they cost.
Neither is right for everyone. The choice should start with your health history, your other medications and your goals.
For many people, the weight comes back. A review of 37 studies published in The BMJ in January 2026 found that people who stopped newer GLP-1 medications regained about 1.8 pounds a month on average, on track to reach their starting weight in roughly a year and a half.
The University of Oxford researchers behind the review also cited real-world data showing about half of people stop GLP-1 treatment within 12 months. That is why maintenance belongs in the first conversation, not the last: daily habits, strength, follow-up visits and, when appropriate, dose adjustments over time.
Rapid weight loss can thin the fat pads that shape the face, leaving cheeks and temples hollow and skin less firm. Social media calls it "GLP-1 face," among other nicknames. Plastic surgeons interviewed by the American Society of Plastic Surgeons describe the popular term as a lay label, not a diagnosis: the same volume loss that comes with aging, happening faster.
Those surgeons generally prefer to wait until weight stabilizes before restoring volume, and to start conservatively. Because Refresh offers medical weight loss and aesthetic care under one roof, the same physician-led team can plan for that timing, from skin-quality treatments to dermal fillers and collagen-stimulating injectables.
Both can be safe when the oversight is real. Refresh offers GLP-1 care in person at its St. Petersburg office and by telehealth for eligible patients anywhere in Florida. Patients can switch between the two when clinically appropriate.
Two checks take about five minutes:
Refresh - Aesthetics & Wellness is a physician-led, family-owned medical aesthetics and wellness practice with nine offices across Florida. Its downtown St. Petersburg office offers medically supervised GLP-1 programs that begin with a one-on-one provider evaluation and lab review, followed by a personalized plan, nutrition and lifestyle guidance, and regular follow-ups. Patients see their plan's cost before treatment begins.
Care at the St. Petersburg office is provided under supervising physician J. Kevin Poitras, M.D. Christopher Senger, M.D., Refresh's chief medical officer, leads Refresh's medical standards and oversees clinical protocols.
The office serves St. Pete, Gulfport, St. Pete Beach, Treasure Island, Madeira Beach and surrounding Pinellas County communities.
Refresh - Aesthetics & Wellness, St. Petersburg
646 1st Ave S, St. Petersburg, FL 33701
(727) 300-5575
Monday through Friday, 9 a.m. to 5:30 p.m.; Thursday until 7:30 p.m.
Request a GLP-1 consultation at Refresh
Medically reviewed by Christopher Senger, M.D., chief medical officer of Refresh - Aesthetics & Wellness. This article is general information, not medical advice. GLP-1 medications are prescription treatments that are not appropriate for everyone, and individual results vary.
This post is an advertorial piece contributed by a Patch Community Partner, a local brand partner. To learn more, click here.
Sign up for free local newsletters and alerts for the
St. Pete Patch
Patch.com is the nationwide leader in hyperlocal news.
Visit Patch.com to find your town today.